Alto Neuroscience, Inc. Dividends
The next dividend date for Alto Neuroscience, Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Alto Neuroscience, Inc. (ANRO)
More About Alto Neuroscience, Inc.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Owning Alto Neuroscience, Inc. Stock on the Dividend Date
If you own Alto Neuroscience, Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Alto Neuroscience, Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Alto Neuroscience, Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Alto Neuroscience, Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Alto Neuroscience, Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Alto Neuroscience, Inc. Dividends
You can contact us any time if you would like to ask questions about Alto Neuroscience, Inc. dividends or anything else related to the stock market.